Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Fennec Pharmaceuticals Inc
FENCCurrent price
6.84 USD
+0.29 USD (+4.43%)
Last closed
8.66 CAD
Company
www.fennecpharma.com
ISIN
CA31447P1009
Sector
Healthcare
Industry
Biotechnology
Exchange
TO
Capitalization
238 613 384 CAD
Yield for 12 month
-0.11 %
1Y
3Y
5Y
10Y
15Y
FENC
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. Address: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
130.72 CADP/E ratio
–Dividend Yield
–Current Year
+66 412 963 CAD
Last Year
+29 690 107 CAD
Current Quarter
+11 071 621 CAD
Last Quarter
+9 743 027 CAD
Current Year
+61 964 756 CAD
Last Year
+27 931 221 CAD
Current Quarter
+10 136 995 CAD
Last Quarter
+7 847 230 CAD
Key Figures FENC
1 year
3 years
5 years
10 years
EBITDA
3 594 717 CAD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-12.96 %
PEG Ratio
–
Return On Equity TTM
-1 005.59 %
Wall Street Target Price
130.72 CAD
Revenue TTM
30 866 641 CAD
Book Value
-0.21 CAD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-65.50 %
Dividend Yield
–
Gross Profit TTM
27 864 053 CAD
Earnings per share
-0.030 CAD
Diluted Eps TTM
-0.030 CAD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-46.71 %
Dividend Analytics FENC
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History FENC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– CAD
Last Split Factor
1:3
Payout Ratio TTM
–
Last Split Date
05.09.2014
Stock Valuation FENC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
11.95
Enterprise Value Revenue
3.45
Price Sales TTM
7.73
Enterprise Value EBITDA
34.22
Price Book MRQ
57.98
Financials FENC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators FENC
For 52 weeks
5.64 CAD
10.13 CAD
50 Day MA
8.37 CAD
Shares Short Prior Month
23 694
200 Day MA
7.96 CAD
Short Ratio
173.29
Shares Short
23 394
Short Percent
0.12 %
BeatStart